Astarte Medical Partners

Astarte Medical is a precision medicine and clinical intelligence company focused on improving health outcomes for preterm infants in the neonatal intensive care unit (NICU). The company's flagship platform, NICUtrition, is an EMR-integrated clinical decision support suite that standardizes feeding protocols, optimizes nutrition, and monitors gut health using predictive analytics. By leveraging a proprietary dataset of clinical and microbial information, Astarte Medical aims to reduce variability in care and address critical issues such as growth failure and gut inflammation. The company also developed the NICUbiome platform to identify nutritional phenotypes and predict growth failure through machine learning. Despite raising over $17 million in venture funding and securing several hospital contracts, Astarte Medical announced it would wind down operations in early 2024 due to challenges in scaling software sales within the hospital market.